Skip to main content
Our Work

Identifying Innovative Technologies to Advance Pharmaceutical Manufacturing

Completed

Topics

The Center for Drug Evaluation and Research (CDER) of the Food and Drug Administration fosters the adoption of innovative technologies by pharmaceutical companies. To assist CDER in those efforts, an ad hoc committee of the National Academies of Sciences, Engineering, and Medicine will produce a consensus report that identifies emerging and upcoming technologies that have the potential to advance pharmaceutical quality and modernize pharmaceutical manufacturing for products regulated by CDER.

About Publications/Resources Past Events

Featured publication

Innovations in Pharmaceutical Manufacturing on the Horizon: Proceedings of a Workshop—in Brief

Workshop_in_brief

·

2022

Emerging technologies have the potential to modernize pharmaceutical manufacturing and advance the quality of drug products. A 2021 report from the National Academies of Sciences, Engineering, and Medicine (the National Academies) identified these innovative technologies, including manufacturing pro...

View details

Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.